Oral Health Research Institute
Indianapolis, Indiana, 46202-2876, United States
NCT Number: NCT07100626
The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to answer are:
* Can BlueCheck® reliably detect early carious lesions with high sensitivity and specificity? * Does BlueCheck® visually reflect changes in remineralized enamel lesions?
BlueCheck® results will be compared against standard diagnostic methods (e.g., Nyvad criteria, Diagnodent readings, surface microhardness) to see if BlueCheck® provides an objective, accurate, and visual method of detecting and monitoring early-stage caries.
Participants will:
* Wear a modified lower partial denture with four mounted enamel specimens for 28 days. * Use only the study-provided fluoride containing toothpaste * Attend weekly clinic visits for removal and laboratory analysis of one enamel specimen per week. * Undergo regular oral health checks and provide diary entries tracking brushing and any adverse events.
This study is active but is not currently recruiting participants.
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46202-2876, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Caries Detection and Monitoring
Time frame: Day 0
BlueCheck will be applied to the early stage enamel carious lesions and visually assessed whether they are highlighted blue
Time frame: Day 0
BlueCheck will be applied to sound enamel samples and visually assessed whether they are highlighted blue.
Time frame: Day 1, 7, 14, 21 and 28
Artificial carious lesions will be remineralised by application of fluoride containing toothpaste. Change in colouration of the lesions before and after remineralization in-situ will be compared to changes in surface microhardness over the same period.
Incisive Technologies Pty Ltd
Industry
In Situ Clinical Trial Investigating the Ability of BlueCheck to Detect and Monitor Active Carious Lesions and Their Remineralization
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07708883
Dental Caries, Stomatognathic Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07688343
Dental Caries, Stomatognathic Diseases
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07691905
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Huế, Vietnam
View Trial DetailsNCT07673952
Dental Caries, Dental Restoration Failure
Ankara, Turkey (Türkiye)
View Trial Details